API
GILD icon

Asset Planning Inc’s Gilead Sciences GILD Stock Holding History

Asset Planning Inc’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$104K Hold
824
– – 0.07% 114
2026
Q1 		$115K Hold
824
– – 0.08% 106
2025
Q4 		$101K Hold
824
– – 0.07% 105
2025
Q3 		$91.5K Hold
824
– – 0.07% 115
2025
Q2 		$91.4K Hold
824
– – 0.07% 112
2025
Q1 		$92.3K Hold
824
– – 0.07% 108
2024
Q4 		$76.1K Buy
+824
New +$74.2K 0.06% 119

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Asset Planning Inc's GILD Position: Q2 2026 in Review

Asset Planning Inc held its Gilead Sciences (GILD) position steady in Q2 2026 at 824 shares worth $104K. The position accounts for 0.07% of the portfolio, ranked #114.

Asset Planning Inc first reported a position in GILD in Q4 2024 and has held it in 7 quarters since. The position peaked at $115K in Q1 2026. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Asset Planning Inc held 824 shares of Gilead Sciences worth $104K as of Q2 2026.
  • Asset Planning Inc left its Gilead Sciences share count unchanged in Q2 2026.
  • Gilead Sciences made up 0.07% of Asset Planning Inc's portfolio in Q2 2026, its #114 holding.
  • Asset Planning Inc first reported a position in Gilead Sciences in Q4 2024 and has held it in 7 quarters since.
  • Asset Planning Inc's Gilead Sciences position peaked at $115K in Q1 2026.
  • 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Asset Planning Inc's 13F filing for Q2 2026, filed 27 Jul 2026.